Prostate Cancer Early Detection, Version 2.2016

被引：252

作者：

Carroll, Peter R. ^{[1
]}

Parsons, J. Kellogg ^{[2
]}

Andriole, Gerald ^{[3
,4
]}

Bahnson, Robert R. ^{[5
,6
]}

Castle, Erik P. ^{[7
]}

Catalona, William J. ^{[8
]}

Dahl, Douglas M. ^{[9
]}

Davis, John W. ^{[10
]}

Epstein, Jonathan I. ^{[11
]}

Etzioni, Ruth B. ^{[12
]}

Farrington, Thomas

Hemstreet, George P., III ^{[13
]}

Kawachi, Mark H. ^{[14
]}

Kim, Simon ^{[15
,16
]}

Lange, Paul H. ^{[17
]}

Loughlin, Kevin R. ^{[18
]}

Lowrance, William ^{[19
]}

Maroni, Paul ^{[20
]}

Mohler, James ^{[21
]}

Morgan, Todd M. ^{[22
]}

Moses, Kelvin A. ^{[23
]}

Nadler, Robert B. ^{[8
]}

Poch, Michael ^{[24
]}

Scales, Chuck ^{[25
]}

Shaneyfelt, Terrence M. ^{[26
]}

Smaldone, Marc C. ^{[27
]}

Sonn, Geoffrey ^{[28
]}

Sprenkle, Preston ^{[29
]}

Vickers, Andrew J. ^{[30
]}

Wake, Robert ^{[31
]}

Shead, Dorothy A.

Freedman-Cass, Deborah A.

机构：

[1] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[2] UC San Diego Moores Canc Ctr, San Diego, CA USA

[3] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[4] Washington Univ, Sch Med, St Louis, MO 63130 USA

[5] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[6] Solove Res Inst, St Louis, MO USA

[7] Mayo Clin, Canc Ctr, Jacksonville, FL USA

[8] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[9] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[10] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[11] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[12] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[13] Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[14] City Hope Comprehens Canc Ctr, Duarte, CA USA

[15] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[16] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[17] Univ Washington, Med Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[18] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[19] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[20] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[21] Roswell Pk Canc Inst, Buffalo, NY USA

[22] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

[23] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[24] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[25] Duke Canc Inst, Durham, NH USA

[26] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL USA

[27] Fox Chase Canc Ctr, Philadelphia, PA USA

[28] Stanford Canc Ctr, Stanford, CA USA

[29] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[30] Mem Sloan Kettering Canc Ctr, New York, NY USA

[31] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 05期

关键词：

HEALTH INDEX PHI; ULTRASOUND-GUIDED BIOPSY; BRCA2 MUTATION CARRIERS; AFRICAN-AMERICAN MEN; FAMILY-HISTORY; RANDOMIZED PROSTATE; DIAGNOSTIC-ACCURACY; BREAST-CANCER; URINARY PCA3; GENE;

D O I：

10.6004/jnccn.2016.0060

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

引用

页码：509 / 519

页数：11

共 70 条

[1]

Abdollah F, 2011, UROLOGY, V77, P921, DOI 10.1016/j.urology.2010.08.048

[2]

Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations [J].

Agalliu, Ilir ;

Gern, Robert ;

Leanza, Suzanne ;

Burk, Robert D. .

CLINICAL CANCER RESEARCH, 2009, 15 (03) :1112-1120

[3]

Andriole Gerald L, 2014, Recent Results Cancer Res, V202, P53, DOI 10.1007/978-3-642-45195-9_6

[4]

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up [J].

Andriole, Gerald L. ;

Crawford, E. David ;

Grubb, Robert L., III ;

Buys, Saundra S. ;

Chia, David ;

Church, Timothy R. ;

Fouad, Mona N. ;

Isaacs, Claudine ;

Kvale, Paul A. ;

Reding, Douglas J. ;

Weissfeld, Joel L. ;

Yokochi, Lance A. ;

O'Brien, Barbara ;

Ragard, Lawrence R. ;

Clapp, Jonathan D. ;

Rathmell, Joshua M. ;

Riley, Thomas L. ;

Hsing, Ann W. ;

Izmirlian, Grant ;

Pinsky, Paul F. ;

Kramer, Barnett S. ;

Miller, Anthony B. ;

Gohagan, John K. ;

Prorok, Philip C. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (02) :125-132

[5]

Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].

Andriole, Gerald L. ;

Grubb, Robert L., III ;

Buys, Saundra S. ;

Chia, David ;

Church, Timothy R. ;

Fouad, Mona N. ;

Gelmann, Edward P. ;

Kvale, Paul A. ;

Reding, Douglas J. ;

Weissfeld, Joel L. ;

Yokochi, Lance A. ;

Crawford, E. David ;

O'Brien, Barbara ;

Clapp, Jonathan D. ;

Rathmell, Joshua M. ;

Riley, Thomas L. ;

Hayes, Richard B. ;

Kramer, Barnett S. ;

Izmirlian, Grant ;

Miller, Anthony B. ;

Pinsky, Paul F. ;

Prorok, Philip C. ;

Gohagan, John K. ;

Berg, Christine D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319

[6]

[Anonymous], 2015, SEER STAT FACT SHEET

[7]

[Anonymous], J NATL CANC I

[8]

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy [J].

Auprich, Marco ;

Augustin, Herbert ;

Budaeus, Lars ;

Kluth, Luis ;

Mannweiler, Sebastian ;

Shariat, Shahrokh F. ;

Fisch, Margit ;

Graefen, Markus ;

Pummer, Karl ;

Chun, Felix K. -H. .

BJU INTERNATIONAL, 2012, 109 (11) :1627-1635

[9]

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study [J].

Bancroft, Elizabeth K. ;

Page, Elizabeth C. ;

Castro, Elena ;

Lilja, Hans ;

Vickers, Andrew ;

Sjoberg, Daniel ;

Assel, Melissa ;

Foster, Christopher S. ;

Mitchell, Gillian ;

Drew, Kate ;

Maehle, Lovise ;

Axcrona, Karol ;

Evans, D. Gareth ;

Bulman, Barbara ;

Eccles, Diana ;

McBride, Donna ;

van Asperen, Christi ;

Vasen, Hans ;

Kiemeney, Lambertus A. ;

Ringelberg, Janneke ;

Cybulski, Cezary ;

Wokolorczyk, Dominika ;

Selkirk, Christina ;

Hulick, Peter J. ;

Bojesen, Anders ;

Skytte, Anne-Bine ;

Lam, Jimmy ;

Taylor, Louise ;

Oldenburg, Rogier ;

Cremers, Ruben ;

Verhaegh, Gerald ;

van Zelst-Stams, Wendy A. ;

Oosterwijk, Jan C. ;

Blanco, Ignacio ;

Salinas, Monica ;

Cook, Jackie ;

Rosario, Derek J. ;

Buys, Saundra ;

Conner, Tom ;

Ausems, Margreet G. ;

Ong, Kai-ren ;

Hoffman, Jonathan ;

Domchek, Susan ;

Powers, Jacquelyn ;

Teixeira, Manuel R. ;

Maia, Sofia ;

Foulkes, William D. ;

Taherian, Nassim ;

Ruijs, Marielle ;

Helderman-van den Enden, Apollonia T. .

EUROPEAN UROLOGY, 2014, 66 (03) :489-499

[10]

Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial [J].

Barocas, Daniel A. ;

Grubb, Robert, III ;

Black, Amanda ;

Penson, David F. ;

Fowke, Jay H. ;

Andriole, Gerald ;

Crawford, E. David .

CANCER, 2013, 119 (12) :2223-2229

← 1 2 3 4 5 6 7 →